claim
The incidental ingestion of psilocybin and other psychedelic secondary metabolites, which have very low toxicity and structurally resemble the neurotransmitter serotonin (5-hydroxytryptamine; 5-HT), may have provided a 'treatment' for serotonin depletion, a challenge recurring during human advancement into a socio-cognitive niche.

Authors

Sources

Referenced by nodes (3)